- This event has passed.
Webinar: Prostate Cancer and Making Sense of nmCRPC Treatment Options
October 28, 2020 @ 11:00 am - 12:30 pm EDT
Episode 1 of 3 in Your Prostate Cancer Questions Answered.
In 2018, patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) were watching and waiting. Two years later there are three novel androgen receptor inhibitors available. But more options mean more questions for doctors and for patients. In this first installment of our prostate cancer Answers Now series, we’ll explore these emerging questions around who should use what when, and why. We will also zoom out to give an overview of the disease and current treatment options. This event will be hosted by AnCan Founder Rick Davis and Len Sierra, AnCan Prostate Cancer Moderator. Dr. Eleni Efstathiou from MD Anderson Cancer Center in Texas and Dr. Tom Beer, Chair of Prostate Cancer Research at OSHU.
Join us for our live webinar on Wednesday, October 28th at 8 am PT/11:00 am ET. Get your question answered live. Send your questions ahead of the program to prostate@patientpower.info. If you are unable to register for the event, reach out to us at comments@patientpower.info.
Register here: https://patientpower.info/events/event/prostate-cancer-and-making-sense-of-nmcrpc-treatment-options/2020-10-28/0800
MORE INFORMATION ON OUR PROSTATE CANCER VIDEO CHAT VIRTUAL SUPPORT GROUP CAN BE FOUND AT: https://ancan.org/prostate-cancer/
